FDA Allows Restricted Use Of Tysabri

The Food and Drug Administration will allow the recalled multiple sclerosis drug Tysabri back to market under very limited conditions. Shares of Biogen Idec Inc. (BIIB) dropped $2.32 to close at $45.39 while Elan Corp. (ELN) stock plunged $2.46 to close at $16.52.